Curmeric- Safety-Community-Quarantine-COVID-19

Safety study of the natural product Curmeric in a quarantined community in primary care due to possible cases of COVID-19.

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

RPCEC

Registry ID

RPCEC00000350

Enrollment

186

Registered

2021-01-22

Start date

2020-09-21

Completion date

Unknown

Last updated

2026-03-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

COVID-19 COVID-19 SARS-CoV2

Interventions

Curmeric. Natural product that contains extracts of Curcuma longa -in intellectual property process- (oral) 4mL gargle / mouthwash after the main meals for 1 month.

Curcuma

Administration, Oral

Plant Extracts

mouthwashes, gargles

Eligibility

Sex/Gender

All

Age

5 Years to 85 Years

Inclusion criteria

Inclusion criteria: All the inhabitants of the building in quarantine because of COVID-19 in primary health care.

Exclusion criteria

Exclusion criteria: Known allergy to Turmeric.

Design outcomes

Primary

Measure	Time frame
Adverse Events-AE (Occurrence of AE (Yes, No); Type of event (name of AE); Intensity of AE (Mild, Moderate, Severe); Result (Recovered, Not recovered, Recovered with sequelae, Death); Required treatment (Yes, No)). Measurement time: 1 month	—

Countries

Cuba

Contacts

Public ContactTania Valdes Gonzalez

Center for Technological Applications and Nuclear Development (CEADEN)

taniajapon@gmail.com

Outcome results

None listed

Source: RPCEC (via WHO ICTRP) · Data processed: Apr 4, 2026